MedTrace Logo

Trait Anxiety and Defensive Networks

NCT02682888 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 131

Last updated 2022-02-11

No results posted yet for this study

Summary

to examine the association between trait and defensive network connectivity and the modulatory effect of oxytocin on it

Conditions

  • Healthy

Interventions

BEHAVIORAL

trait anxiety scale

splitting subjects into 2 groups according to scores of the trait anxiety scale

DRUG

Oxytocin

intranasal administration of oxytocin

DRUG

Placebo

intranasal administration of placebo

Sponsors & Collaborators

  • University of Electronic Science and Technology of China

    lead OTHER

Principal Investigators

  • Keith Kendrick, Dr. · University of Electronic Science and Technology of China

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-08
Primary Completion
2021-08-19
Completion
2021-11-20

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02682888 on ClinicalTrials.gov